Clinical Trials Logo

Clinical Trial Summary

This study will test any good and bad effects of aerobic exercise performed while you are receiving the usual first-line treatment for metastatic breast cancer. The researchers think that exercise helps delay the development of resistance to hormone therapy while slowing the growth of tumors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03988595
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact Neil Iyengar, MD
Phone 646-888-4714
Email iyengarn@mskcc.org
Status Recruiting
Phase Phase 1
Start date June 12, 2019
Completion date August 1, 2024